Interestingly, we observed that the class I-specific HDAC inhibitor mocetinostat was additive in radiosensitising FaDu cells grown in 3D, whereas this was acting synergistically through clonogenic survival assays in all three HNSCC cell lines. This evidence concerns the gene HDAC9 and head and neck squamous cell carcinoma.